Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer

BACKGROUND: Despite the rapid adoption of immunotherapies in advanced non–small cell lung cancer (advNSCLC), knowledge gaps remain about their real‐world (rw) performance. METHODS: This retrospective, observational, multicenter analysis used the Flatiron Health deidentified electronic health record‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Khozin, Sean, Miksad, Rebecca A., Adami, Johan, Boyd, Mariel, Brown, Nicholas R., Gossai, Anala, Kaganman, Irene, Kuk, Deborah, Rockland, Jillian M., Pazdur, Richard, Torres, Aracelis Z., Zhi, Jizu, Abernethy, Amy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899461/
https://www.ncbi.nlm.nih.gov/pubmed/31381142
http://dx.doi.org/10.1002/cncr.32383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899461/
https://www.ncbi.nlm.nih.gov/pubmed/31381142
http://dx.doi.org/10.1002/cncr.32383

Ejemplares similares